In 2016, I joined a company that specialized in therapeutic candidate discovery targeting GPCR ( Confo Therapeutics ) as a team and project leader for antibody discovery for metabolic and inflammatory diseases GPCR Ecosystem G.CLIPS Biotech on the web Website LinkedIn Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

, and serves as Deputy Director of the Australian Research Council Centre for Personalised Therapeutics Institute of Medical Research, Deputy Director of the Australian Research Council Centre for Personalised Therapeutics GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

collaborative neuroscience R&D program with Servier (France) and is the co-founder and CEO of Phrenix Therapeutics , a biotech spin-out from the Neuromedicines Discovery Centre that is developing next-generation therapeutics Prior to these roles this he was Head of Pharmacology at Heptares Therapeutics Ltd., a UK-based biotechnology These successes enabled the US$400M sale of Heptares Therapeutics Ltd. to the Sosei Group Corporation GPCR Podcast? Leave a Review.

Milligan is the co-founder of both Caldan Therapeutics (2015) which discovers novel therapeutics for indications including non-alcoholic steatohepatitis (NASH) and inflammatory diseases and Keltic Pharma Therapeutics GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

Terry Hebert is a Professor of Pharmacology and Therapeutics at McGill University. The goal is to test therapeutic strategies targeting the AT1R, alpha-adrenergic, and beta-adrenergic Drugging GPCRs on the Nuclear Membrane GPCRs are not confined to the cell surface. Dr. GPCR Ecosystem Unlock the Full Dr. GPCR Podcast? Leave a Review.

The therapeutic logic that follows is less about attacking the virus and more about rebalancing a GPCR-driven density and tissue-specific therapeutic opportunity — type II pneumocytes, beta-2 receptors, and the The review was accepted at Clinical Pharmacology and Therapeutics within weeks. If the virus disrupts one arm of this receptor-peptide system, the therapeutic question stops being " GPCR Podcast? Leave a Review.

He received the Canadian Society of Pharmacology and Therapeutics Postdoctoral and Publication awards along with many Young Scientist Awards from the American Society for Pharmacology and Experimental Therapeutics GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

Michael Feigin is an Associate Professor in the Department of Pharmacology and Therapeutics, and Director of Graduate Studies of Experimental Therapeutics at Roswell Park Comprehensive Cancer Center in Buffalo disrupting histone processing on rapidly proliferating cells, such as cancer cells, and suggested a therapeutic GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

of GPCR science. Sep 20, 2022 — First contributor article published: Therapeutic validation of an orphan G protein‐coupled May 2022 — Media Partner at GPCR Retreat . Jul 2022 — Media Partner at GPCR ECI Transatlantic . GPCR University with the first GPCR Course led by Dr. Terry Kenakin , enrolling 30+ students . GPCR Team . May 16, 2024 — Episode #151 featured the Dr. GPCR Board .

Class C GPCRs are structural and mechanistic outliers within the GPCR superfamily. mutations in the GABA-B transmembrane domain and what they suggest about precision pharmacology The therapeutic But its therapeutic window is narrow. GPCR Ecosystem Unlock the Full Dr. GPCR Podcast? Leave a Review.

<< Back to podcast list Strategic Partner(s) The Role of Quantitative Sciences in GPCRs with Dr. She has advanced the use of computational methods to meet the challenges of designing therapeutics with GPCR Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

Foord reflects on discovering RAMPs, deorphanizing GPCRs, and navigating industrial GPCR pharmacology Key Insights from the Conversation RAMPs Reframed Peptide GPCR Pharmacology . Dr. Later hepatotoxicity concerns and the success of antibody therapeutics further shifted strategy. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

. << Back to podcast list Strategic Partner(s) Silvio Gutkind: When GPCRs Drive Cancer GPCRs are the The canonical assumption that targeting PLC would be therapeutic has failed in the clinic, and patients GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional therapeutics that interdict diseases based on their gerontological underpinnings. GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional therapeutics that interdict diseases based on their gerontological underpinnings. GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional therapeutics that interdict diseases based on their gerontological underpinnings. GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

Terry Kenakin on tuning GPCR system sensitivity to reveal true drug activity. September 24, 2026. , with 25+ years of expertise and validated cell-based assays spanning basic research through therapeutic GPCR Dr. GPCR is a membership-based nonprofit ecosystem dedicated to advancing GPCR-targeted drug discovery. opportunities for scientists and biotech leaders working across pharmacology, translational research, and therapeutic

Whether you’re decoding signaling pathways or designing the next generation of therapeutics, Revvity View Reagents Explore Revvity’s GPCR Assay Technologies Tools designed to illuminate every step of GPCR GPCR, the global nonprofit platform dedicated to advancing GPCR research and drug discovery, is proud GPCR Podcast Oct 16, 2025 4 min read The Truth About GPCR Product Launches: Years in the Making What GPCR Podcast Sep 26, 2025 3 min read Dr. GPCR Ecosystem Partner Contact Revvity

His lab has shown a role for -arrestins and PTMs in GPCR trafficking and signaling and has leveraged The ultimate goal of Adriano’s research is to target novel aspects of GPCR signaling for therapeutic GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

structural biology and drug discovery, where molecular structures inform the design and development of new therapeutics GPCR Drug Discovery Is Increasingly Structural Modern GPCR drug discovery increasingly integrates structural What is your favorite GPCR? Dr. You could easily imagine separate therapeutic programs targeting those different physiological effects GPCR Podcast? Leave a Review.

Brian Collier in the Department of Pharmacology and Therapeutics at McGill University (1994). GPCR Ecosystem Great Lakes GPCR Retreat on the web 21st Great Lakes GPCR Retreat More about previous GPCR Retreat meetings Dr. GPCR Ecosystem Unlock the Full Dr. GPCR Podcast? Leave a Review.

, named GPCR-CoINPocket. from ‘locked’, inaccessible receptors to well-characterized and understood ‘unlocked’ therapeutic targets GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

GPCR Podcast , I spoke to Dr. record as a biologics leader as he led teams to discover and develop novel first-in-class antibody therapeutics GPCR podcast. Dr. GPCR Ecosystem Unlock the Full Dr. GPCR Podcast? Leave a Review.

biosensors, cryo-EM, photoswitchable ligands, and nanobodies as pharmacological tools and potential therapeutic and the asymmetric functioning of GPCR dimers. GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

Specifically, I am interested in understanding dysregulated G-protein coupled receptor (GPCR) signaling receptors would be a significant breakthrough in cardiovascular biology as they could be targeted for therapeutic GPCR Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

He received the Canadian Society of Pharmacology and Therapeutics Postdoctoral and Publication awards along with many Young Scientist Awards from the American Society for Pharmacology and Experimental Therapeutics test the feasibility of using protein-targeted degradation as a therapeutic strategy. " Victoria Rasmussen Maddi is currently a second year Ph.D. student in the Molecular Pharmacology and Therapeutics (MPaT) GPCR Unlock the Full Dr.

He is the scientific founder of two biotech companies, ModMab Therapeutics , and AntlerA Therapeutics GPCR Ecosystem LinkedIn Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

GPCR signaling in disease. << Back to podcast list Strategic Partner(s) Hacking GPCRs: Tools, Tech & Beyond GPCR-RAMP: New Avenues “What if your favorite scaffold protein interacts with GPCRs?” This could accelerate discovery of therapeutic targets by combining multiplex data with focused downstream GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

GPCR Brand Features. Your use of the Dr. GPCR Brand Features will inure to the benefit of Dr. GPCR. GPCR button. GPCR development of Dr. GPCR Buttons. By using a Dr. GPCR button, Publishers give Dr. GPCR button. GPCR buttons.

motivated behavior and how these receptors can be targeted for therapeutic benefit. distinct signaling pathways with their physiological effects and may serve as the basis for more selective therapeutics GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.